Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A monoclonal antibody used as an immunosuppressive drug.

Etymologies

from Wiktionary, Creative Commons Attribution/Share-Alike License

-li- +‎ -zu- +‎ -mab

Examples

  • Two new government-funded studies—one using oral insulin and the other an experimental compound called teplizumab—are renewing hope that prevention is possible.

    Trying to Prevent Type 1 Diabetes

  • On Wednesday, the company said a potential type 1 diabetes treatment called teplizumab failed in a late-stage clinical trial.

    The Seattle Times

  • Another possible route to prevention is being investigated in a second TrialNet study focused on the compound teplizumab.

    Trying to Prevent Type 1 Diabetes

  • Other recent disappointments have included the failures of Bydureon, developed with Amylin AMLN, and teplizumab, developed with MacroGenics.

  • PDL BioPharma says Lilly licensed teplizumab, a potential drug for newly diagnosed diabetes Lilly licenses PDL type 1 diabetes drug candidateNEW YORK - PDL BioPharma Inc. said Monday that Eli Lilly

    Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7

  • J, foundation to start testing of artificial pancreas in insulin-dependent diabetics PDL BioPharma says Lilly licensed teplizumab, a potential drug for newly diagnosed diabetes

    Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7

  • At the end of last year, we successfully executed a new license with Eli Lilly for teplizumab, an exciting product being investigated in pivotal trials for recent onset type 1 diabetes.

    SeekingAlpha.com: Home Page

  • The company's lead program, teplizumab, is an anti-CD3 antibody being developed for the treatment of autoimmune diseases.

    The Earth Times Online Newspaper

  • Monitoring Committee (DMC) completed a planned analysis of one-year safety and efficacy data of the Protege Phase 3 clinical trial of teplizumab, an investigational biologic under development for the treatment of individuals with recent-onset type 1 diabetes.

    Lilly Reports Third-Quarter 2010 Results - Yahoo! Finance

  • The companies have decided to suspend further enrollment and dosing of patients in two other ongoing clinical trials of teplizumab in type 1 diabetes and are currently evaluating the next steps for teplizumab.

    Lilly Reports Third-Quarter 2010 Results - Yahoo! Finance

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.